Comparing Bleeding and Mortality Risks of Dabigatran vs. Rivaroxaban in Elderly Medicare Beneficiaries
A study by DJ Graham et al. compared the risks of stroke, bleeding, and mortality in elderly Medicare beneficiaries with nonvalvular atrial fibrillation treated with dabigatran or rivaroxaban. The study included over 118,000 patients and found that dabigatran was associated with a lower risk of majo
0 views • 9 slides
Understanding Anticoagulants and Their Indications
Explore the world of anticoagulants through images, covering different types like warfarin and NOACs, their indications such as AF, DVT, and PE, monitoring in clinics, and specific drug details like apixaban, rivaroxaban, dabigatran, and edoxaban. Get insights into dosages, administration, and drug
0 views • 27 slides